Andrew J Gow

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 62(Granted Patents)

Location History:

Doylestown, PA (US) (2005)
Durham, NC (US) (2001 - 2007)
Princeton, NJ (US) (2014 - 2024)

Company Filing History:

Rutgers, the State University of New Jersey

patents

1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343351 - Pulmonary function treatment (2025-07-01),

2. 12082914 - Evaluation system for cardiovascular health assessment and individualized health and fitness interventions (2024-09-10),

3. 11330986 - Evaluation system for cardiovascular health assessment and individualized health and fitness interventions (2022-05-17),

4. 10670580 - Quantification of inflammatory molecules in exhaled breath condensate using differential pulse voltammetry on reduced graphene oxide sensor (2020-06-02),

5. 8871506 - Methods for treating cardio pulmonary diseases with NO group compounds (2014-10-28),

6. 7202340 - No-modified hemoglobins and uses therefor (2007-04-10),

7. 6945247 - Method of treating cardio pulmonary diseases with no group compounds (2005-09-20),

8. 6884773 - Modified hemoglobins, including nitrosylhemoglobins, and uses thereof (2005-04-26),

9. 6627738 - No-modified hemoglobins and uses therefor (2003-09-30),

10. 6314956 - Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders (2001-11-13),

Title: The Innovations of Andrew J Gow

Introduction

Andrew J Gow is a prominent inventor based in Princeton, NJ, known for his significant contributions to the field of pulmonary function and cardiovascular health. With a total of 10 patents to his name, Gow has made strides in developing innovative methods and systems that enhance health assessments and treatments.

Latest Patents

One of his latest patents focuses on pulmonary function treatment. This method involves administering an effective dose of a Farnesoid X Receptor (FXR) agonist, particularly obeticholic acid, to treat reduced pulmonary function. Additionally, he has developed an in vivo animal model of lung injury and altered functioning, which is useful for identifying compounds that can restore pulmonary function. Another notable patent is an evaluation system for cardiovascular health assessment and individualized health and fitness interventions. This system generates a cardiovascular health assessment score that reflects tissue flow and indicates dependence on central and peripheral control mechanisms. It supports various individualized medicine and health applications, enhancing the overall effectiveness of health interventions.

Career Highlights

Gow has worked with esteemed institutions such as Duke University and Rutgers, the State University of New Jersey. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jonathan S Stamler and Eric John Toone. Their collaborative efforts have further advanced the research and development of innovative health solutions.

Conclusion

Andrew J Gow's contributions to pulmonary function and cardiovascular health through his patents and collaborations highlight his role as a significant innovator in the medical field. His work continues to pave the way for advancements in health treatments and assessments.

This text is generated by artificial intelligence and may not be accurate.